{
    "clinical_study": {
        "@rank": "28271", 
        "arm_group": {
            "arm_group_label": "Cardiac PET scan, Coronary catheterization", 
            "description": "Cardiac PET scan:\nInjection of N-13 Ammonia radionuclide. 2 doses of 10 milliCuries and 20 milliCuries each.\nInjection of Lexiscan.\nCoronary catheterization:\nPressure and flow readings using Combowire\nInjection of Adenosine."
        }, 
        "brief_summary": {
            "textblock": "Diagnosis of relative contributions of large artery blockages and microvascular blockages is\n      very much needed in the treatment of coronary artery disease. In order to achieve this, two\n      novel parameters, pressure drop coefficient (CDP), which combines flow and pressure readings\n      and Lesion flow coefficient (LFC), which combines anatomical details of the lesion with\n      pressure and flow readings, are being investigated. The diagnostic parameters will be\n      correlated with Coronary Flow Reserve (CFR)values obtained using Positron Emission\n      Tomography (PET) imaging. They will also be correlated with Fractional Flow Reserve (FFR)."
        }, 
        "brief_title": "Improvement Assessment of Coronary Flow Dysfunction Using Fundamental Fluid Dynamics", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years of age or above\n\n          -  Patients referred to a stress test by a Cardiologist\n\n          -  Acute Chest pain, as per patient input.\n\n          -  Risk Assessment with prior test results and/or previous history of known chronic\n             stable CAD.\n\n          -  Borderline or discordant stress testing where obstructive CAD remains a concern.\n\n          -  New or worsening symptoms- Abnormal coronary angiography or abnormal prior stress\n             imaging study.\n\n          -  Coronary stenosis or anatomic abnormality of uncertain significance.\n\n          -  In absence of reliable diagnostic information from another imaging modality.\n\n        Exclusion Criteria:\n\n          -  Left ventricular ejection fraction less the 25% determined by gated SPECT  imaging\n\n          -  Non-dialysis dependent chronic kidney disease with baseline serum creatinine greater\n             than 2.5 gm/dL.\n\n          -  History of type II heparin-induced thrombocytopenia.\n\n          -  Significant co-morbid condition that is medically unstable and would make coronary\n             angiography prohibitive or contraindicated.\n\n          -  Pregnant women.\n\n          -  Incapacitated for Consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with chest pain and suspected ischemia that needs to be assessed by a stress test"
            }
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 29, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01719016", 
            "org_study_id": "10-05-05-02"
        }, 
        "intervention": {
            "arm_group_label": "Cardiac PET scan, Coronary catheterization", 
            "description": "Patients would under go a Cardiac rest and stress PET scan and include the following drug administration:\nN-13 Ammonia radionuclide - Two doses, 10 mCi for rest, 20 mCi for stress\nLexiscan - stress agent for PET scan\nPatients would also undergo Coronary catheterization including the following drug administration and device usage:\nCombowire to obtain pressure and flow readings on Combomap machine (Volcano Therapeutics, CA).\nAdenosine - stress agent during catheterization, 140 ug/Kg/min", 
            "intervention_name": "Cardiac PET scan, Coronary catheterization", 
            "intervention_type": "Procedure", 
            "other_name": [
                "Volcano therapeutics", 
                "Combomap machine", 
                "Adenosine", 
                "Lexiscan", 
                "N-13 Ammonia"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": "Adenosine"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Reversible ischemia", 
            "microvascular dysfunction"
        ], 
        "lastchanged_date": "January 13, 2013", 
        "location": {
            "contact": {
                "email": "stephanie.zazycki@va.gov", 
                "last_name": "Stephanie Zazycki", 
                "phone": "513-861-3100", 
                "phone_ext": "4080"
            }, 
            "facility": {
                "address": {
                    "city": "Cincinnati", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "45220"
                }, 
                "name": "Cincinnati Veteran Affairs Medical Center"
            }, 
            "investigator": {
                "last_name": "Rupak K Banerjee, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Improvement Assessment of Coronary Flow Dysfunction Using Fundamental Fluid Dynamics", 
        "overall_contact": {
            "email": "rupak.banerjee@uc.edu", 
            "last_name": "Rupak K Banerjee", 
            "phone": "5135562124"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Cincinnati , CVAMC", 
                "last_name": "Rupak K Banerjee, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Univesity of Cincinnati, University Hospital", 
                "last_name": "Mohamed Effat, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Cincinnati and University Hospital", 
                "last_name": "Imran Arif, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Cincinnati", 
                "last_name": "Kranthi K Kolli, MS", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Cincinnati", 
                "last_name": "Srikara Viswanath Peelukhana, MS", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Cincinnati", 
                "last_name": "Hanan Kerr, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Cincinnati", 
                "last_name": "Mariono Fernandez-Ulloa, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Correlation Coronary Flow Reserve (CFR) from Positron Emission Tomography (PET)imaging with diagnostic parameters, Pressure Drop Coefficient (CDP) and Lesion Flow Coefficient (LFC).", 
            "measure": "Quantification of relative contributions of large artery disease and microvascular disease", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01719016"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Correlation of CDP and LFC with invasively measured Fractional Flow Reserve (FFR) values.", 
            "measure": "Quantification of relative contributions of large artery disease and microvascular disease", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "University of Cincinnati", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Cincinnati", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2010", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2013"
    }
}